Correction: Prognostic indicators of disease progression in Duchenne muscular dystrophy: A literature review and evidence synthesis.

Autor: Ferizovic N, Summers J, de Zárate IBO, Werner C, Jiang J, Landfeldt E, Buesch K

Publikováno v: PloS one [PLoS One] 2024 Dec 09; Vol. 19 (12), pp. e0315682. Date of Electronic Publication: 2024 Dec 09 (Print Publication: 2024).

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

HPR68 Timing of Initiation of Clinical Interventions in Patients with Duchenne Muscular Dystrophy: A Systematic Review and Grading of the Evidence

Autor: Landfeldt, E, Ferizovic, N, Buesch, K

Publikováno v: In Value in Health July 2022 25(7) Supplement:S478-S479

Prognostic indicators of disease progression in Duchenne muscular dystrophy: A literature review and evidence synthesis.

Autor: Ferizovic N; MAP BioPharma Ltd, Cambridge, England, United Kingdom.; BresMed Health Solutions, Sheffield, England, United Kingdom., Summers J; MAP BioPharma Ltd, Cambridge, England, United Kingdom., de Zárate IBO; PTC Therapeutics France SAS, Paris, France., Werner C; PTC Therapeutics Germany GmbH, Frankfurt/Main, Germany., Jiang J; PTC Therapeutics, South Plainfield, New Jersey, United States of America., Landfeldt E; ICON plc, Stockholm, Sweden., Buesch K; PTC Therapeutics Switzerland GmbH, Zug, Switzerland.

Publikováno v: PloS one [PLoS One] 2022 Mar 25; Vol. 17 (3), pp. e0265879. Date of Electronic Publication: 2022 Mar 25 (Print Publication: 2022).

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.